Hypereosinophilic Syndrome Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025
Hypereosinophilic syndrome is a disorder that affects a person with a significant rise in the number of eosinophils, which affects the immune system. With a tremendous rise, the condition affects the organs of the human body, resulting in a severe and fatal condition, if not treated. As a result, a large number of medications and therapeutics are available across the globe to treat this condition, which is expected to encourage the growth of the global hypereosinophilic syndrome market in the next few years.
The rising focus of the prominent players operating in the global hypereosinophilic syndrome market on the development of new and effective treatments and the increasing expenditure on research and development activities are projected to accelerate the growth of the overall market in the next few years. Furthermore, with the rising support from government organizations and the development of the healthcare facilities and infrastructure are projected to supplement the development of the overall market in the forecast period.
The increasing awareness among patients regarding this condition and the availability of effective therapeutics are projected to bolster the hypereosinophilic syndrome market in developed economies. On the contrary, the lack of knowledge and the absence of required healthcare infrastructure are estimated to restrict the growth of the market, particularly in developing economies in the next few years. The development of modern therapeutics and the increasing number of players with a strong drug pipeline are considered as the key factors that are likely to contribute substantially towards the development of the global hypereosinophilic syndrome market in the next few years.
Hypereosinophilic syndrome (HES) is a myeloproliferative disorder, which is characterized by persistently increased eosinophil count in blood and is associated with damage to multiple organs. The syndrome, though a rare disease but can become life-threatening, if left untreated. The tests taken for its diagnosis include blood tests, bone marrow biopsy, and echocardiography. Some of the commonly available treatment options are drug medications, anticoagulants and antiplatelets, antihistamines, splenectomy, and bone marrow transplant.
The primary objective of the report is to provide a 360-degree view of the global hypereosinophilic syndrome market. The objective has been fulfilled by meticulously examining various aspects of the market including its dynamics, trends, clinical advancements, geographical segmentation, and competitive landscape. The information regarding the market is gathered from various paid and unpaid sources such as press releases, journals, presentations, and white papers. The report profiles key players in the global hypereosinophilic syndrome market along with their business strategies, latest development, market shares, and revenue structures. It also includes a separate section of recommendations for new as well as existing players in the market, thereby serving as a reliable business tool. It provides an overview of the pipeline therapeutics.
The global hypereosinophilic syndrome market is likely to tread along a healthy growth track with the rising incidence of endocrine and autoimmune disorders. Favorable government initiatives also play a vital role in the growth of the market as they help in spreading awareness regarding the fatal effects of hypereosinophilic syndrome. Moreover, the improving healthcare infrastructure in emerging economies is working in favor of the growth of the market. Furthermore, the increasing research activities for the development of advanced treatment therapies is creating ample growth opportunities for the market. For instance, the use of tyrosine kinase inhibitors such as Gleevec is one of the new approaches for controlling malignant cell growth.
On the basis of geography, the global hypereosinophilic syndrome market can be fragmented into Asia Pacific, Europe, North America, and Rest of the World. North America and Europe account for a large collective share in the market. The growing prevalence of autoimmune diseases and endocrine disorders is the primary factor driving the growth of these regions. The rising awareness regarding the malignant effects of hypereosinophilic syndrome and development of modern therapies for its treatment are providing a fillip to the market in these regions.
Asia Pacific is expected to witness a tremendous growth during the same period, thanks to favorable reimbursement policies and the presence of policies that offer tax benefits. Factors such as expanding patient base, improving healthcare infrastructure, and increasing incidence of anemia are also influencing the growth of the region positively.
The global hypereosinophilic syndrome market is characterized by the presence of large biopharmaceutical players. Some of the key players in the market are GlaxoSmithKline Plc., Bristol-Myers Squibb Company, Kyowa Hakko Kirin Co Ltd, Knopp Biosciences LLC, and Stemline Therapeutics Inc. These players are investing sizeable funds in the development of novel treatment therapies in order to strengthen their position in the market.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report